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ABSTRACT
BACKGROUND: An increased prevalence of autoimmune disorders, including 
thyroid diseases, has been reported in patients with celiac disease (CD). This study 
aimed to identify the prevalence of thyroid-related abnormalities in adults with CD.
METHODS: Thirty-nine subjects with biopsy-proven CD, three men (7.7%) and 
36 women (92.3%), answered a questionnaire. All patients were followed at the 
outpatient clinic of Hospital de Clínicas de Porto Alegre. Thyroid-related abnormalities 
were evaluated by serum thyroid stimulating hormone (TSH), free thyroxine (FT4) 
and anti-thyroperoxidase antibodies (anti-TPO) levels.
RESULTS: Three subjects had grade 1 lesions; one had grade 2; 13 had grade 
3a; eight had grade 3b; and 14 had grade 3c, according to the modified Marsh 
classification. Mean age was 50.8 ± 12.9 years. Twenty-nine (74.4%) subjects were 
euthyroid. Ten subjects (25.6%) had hypothyroidism: eight of them (20.5%) were 
already taking levothyroxine, and subclinical hypothyroidism was identified during 
the study in the other two patients (5.1%). No patients were hyperthyroid. Mean 
serum FT4 levels were 1.15 ± 0.25 ng/dl. Median serum TSH levels were 2.39 (0.06-
6.64)IU/ml. Serum anti-TPO levels were positive in six patients (15.4%): one with 
hypothyroidism, one with subclinical hypothyroidism, and four with normal thyroid 
function. No factors associated with thyroid-related abnormalities were identified.
CONCLUSION: This study showed a high prevalence of thyroid-related abnormalities, 
as did other studies. Since anti-thyroid antibodies were positive in some patients 
with normal thyroid function, periodic evaluation of thyroid function in CD patients is 
recommended.
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RESUMO
INTRODUÇÃO: Tem-se observado um aumento na prevalência de doenças auto-
imunes, incluindo doenças da tireoide, em pacientes com doença celíaca (DC). 
O objetivo deste estudo foi identificar a prevalência de alterações da tireoide em 
adultos com DC. 
MÉTODOS: Trinta e nove indivíduos com diagnóstico comprovado de DC, três 
homens (7,7%) e 36 mulheres (92,3%), responderam a um questionário. Todos os 
pacientes foram acompanhados no ambulatório do Hospital de Clínicas de Porto 
Alegre, alterações relacionadas à tireoide foram detectadas por meio da medição 
dos níveis de hormônio estimulador da tireoide (TSH), tiroxina livre (T4 livre) e 
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Celiac disease (CD) is a small intestine disorder 
triggered by gluten proteins found in wheat, barley, 
and rye (1). It is a worldwide disorder, more common in 
Western countries; in Europe and in the United States, 
the prevalence of CD is 1% (2,3). Celiac individuals 
are genetically predisposed to developing the 
disease, specially when under the right environmental 
conditions (4). CD is considered a multi-organ 
condition, linked to a number of diseases, including 
autoimmune diseases (1,3,5). 
The age of onset may vary (6). CD has a wide 
clinical spectrum, ranging from malabsorption 
syndrome to extraintestinal manifestations, and 
it can be atypical or even asymptomatic (7). 
Serological tests are useful for screening. The 
diagnosis is confirmed by histological abnormalities. 
CD’s association with autoimmune disorders 
causes increased morbidity and mortality. The 
risk of autoimmune thyroid diseases, such as 
Hashimoto’s thyroiditis and Graves’ disease, is 
much higher in celiac patients (3). Moreover, it has 
been shown that 14 to 30% of adults with CD may 
have autoimmune thyroid disease (ATD) (8). 
Acknowledgment of the link between CD and 
ATD is important for disease management. Untreated 
autoimmune diseases, such as ATD, may cause high 
morbidity among celiac patients. Also, untreated CD 
may interfere with the course of other autoimmune 
diseases (9). For instance, when type 1 diabetes 
mellitus and CD coexist, treatment of CD improves 
glucose control, which reinforces the need to 
follow a gluten-free diet (GFD) (9). In patients with 
Hashimoto’s thyroiditis or Graves’ disease, an 
inadequate response to treatment may indicate the 
presence of CD (9).
A study by Elfström et al. showed a significant 
risk of increased hyperthyroidism in CD (3).
Hakanen et al. showed that 10-15% of celiac 
patients had positive antithyroid antibodies, which 
suggests that the prevalence of subclinical forms 
of ATD may be even higher (10). Nevertheless, 
the significance of anti-thyroperoxidase (anti-TPO) 
positivity is still unclear when thyroid function tests 
are normal (10).
Since the prevalence of CD and thyroid-related 
abnormalities is linked to genetic and environmental 
factors, the aim of this study was to identify the 
prevalence of thyroid-related abnormalities in adult 
patients with CD followed at the outpatient clinic of 
Hospital de Clínicas de Porto Alegre, in southern 
Brazil.
METHODS
A total of 1.276 duodenal biopsies were performed 
in the Hospital de Clínicas de Porto Alegre, Brazil, 
from January 2007 to May 2009 (29 months).We 
went over all the pathology tests results. We selected 
165 biopsies, all of which showed some abnormality 
possibly related to CD, such as increased intra-
anticorpos antitireoperoxidase (anti-TPO), no soro.
RESULTADOS: Três pacientes apresentavam lesões tipo 1; um paciente apresentava 
tipo 2; 13 pacientes, tipo 3a; oito pacientes, tipo 3b; e 14 tipo 3c, de acordo com a 
classificação modificada de Marsh. A média de idade foi de 50,8 ± 12,9 anos. Vinte 
e nove (74,4%) pacientes apresentaram tireoide nomal. Dez indivíduos (25,6%) 
apresentaram hipotireoidismo: oito pacientes (20,5%) já usavam levotiroxina e 
dois pacientes (5,1%) com hipotireoidismo subclínico foram identificados durante a 
avaliação. Nenhum paciente apresentou hipertireoidismo. Os níveis médios séricos 
de T4L foram 1,15 ± 0,25 ng/dl. A mediana do TSH sérico foi 2,39 (0,06-6,64) UI/
ml. Níveis séricos de anti-TPO foram positivos em seis pacientes (15,4%), um com 
hipotireoidismo, um com hipotireoidismo subclínico e quatro com função tireoidiana 
normal. Não se identificou fator associado a anormalidades relacionadas à tireoide.
CONCLUSÃO: Este estudo demonstrou uma alta prevalência de anormalidades 
tireoidianas, como observado em outros estudos. Uma vez que os anticorpos 
antitireoide estavam presentes em alguns pacientes com função tireoidiana normal, 
recomenda-se a avaliação periódica da função tireoidiana em pacientes com DC.
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epithelial lymphocytes, villous hyperplasia, or atrophy. 
After that, we analyzed all 165 patients’ records. 
Fifty-six of them were diagnosed with CD by their 
physicians. Six patients refused to participate in this 
study for different reasons, mostly because they 
lived far from the hospital; one patient was deceased; 
and 17 patients could not be reached. We included 
seven patients obtained by convenience sampling. 
The final sample was composed of 39 patients.
Trained physicians diagnosed CD based on clinical 
findings and/or positivity in serologic auto-antibodies, 
and histological criteria. Severity of CD was ranked 
using the Marsh classification. Adulthood was defined 
as beginning at age 18.
Specimens of intestinal mucosa were obtained 
through upper gastrointestinal endoscopy. Histological 
criteria were revised by two pathologists, both 
experts on CD, and classified into types 1, 2, 3a, 3b, 
and 3c (11,12), according to the Marsh-Oberhuber 
classification.
All data on associated diseases were obtained 
from interviews and electronic medical records. All 
subjects were submitted to a standard interview 
We collected data regardingdemographics, clinical 
findings, compliance with GFD, symptoms, and 
serologic data (thyroid function tests and anti-
thyroperoxidase antibodies)for each patient. We 
onlyrecorded diseases described as CD-related in 
medical literature: iron deficiency anemia, lactose 
intolerance, anemia due to folic acid deficiency, 
osteopenia and osteoporosis, type 1 diabetes 
mellitus, dermatitis herpetiformis, and IgA 
deficiency. 
We collected blood samples from each subject. 
Blood was immediately centrifuged at 4000×g 
for 10 minutes. Serum was assayed for anti-TPO 
(normal range: less than 34 IU/ml; intra- and inter-
assay coefficient of variation, respectively, 6.3% and 
9.5%), TSH (normal range: 0.27 to 4.2 IU/ml; intra- 
and inter-assay coefficient of variation, respectively, 
3.0% and 7.2%), and free T4 (FT4) (normal 
range: 0.93 to 1.70 ng/dl; intra- and inter-assay 
coefficient of variation, respectively, 2.0% and 4.8%) 
levels. Chemiluminescence was performed using 
commercial kits (Roche Diagnostics, Mannheim, 
Germany).
Thyroid function was classified according to 
the American Thyroid Association (13). Overt 
hyperthyroidism was defined by a decrease in 
serum TSH levels and an increase in serum FT4 
levels; subclinical hyperthyroidism was defined by 
decreased serum TSH levels and normal serum 
FT4 levels; overt hypothyroidism was defined by 
an increase in serum TSH levels and a decrease in 
serum FT4 levels; and subclinical hypothyroidism 
was defined by an increase in serum TSH levels 
with normal serum FT4 levels. Subjects were 
diagnosed with euthyroid autoimmune thyroid 
disease  when anti-TPO was above 34 UI/mL with 
normal thyroid function.
We performed thestatistical analysis using 
SPSS 17.0. Variables with parametric distribution 
were presented as mean ± standard deviation (SD) 
or percentage (%), as appropriate. Variables with 
non-parametric distribution were shown as median 
and interquartile range. We used chi-square tests 
to evaluate associations between categorical 
variables. Differences in means between groups 
were evaluated using the t-test or the Mann-
Whitney test according to data distribution. Two-
tailed p values <0.05 were considered to be 
statistically significant. 
All participants signed a written consent before 
joining the study, which was approved by the local 
ethics committee.
RESULTS
Thirty-nine patients with CD, 36 women 
(92.3%) and 3 men (7.7%), were included: three 
patients had grade 1 lesions; one had grade 2; 
13 had grade 3a; eight had grade 3b; and 14 
had grade 3c, according to the modified Marsh 
classification. Mean age was 50.8 ± 12.9 years.
Out of 39 patients, 29 (74.4%) were euthyroid. Ten 
subjects (25.6%) had thyroid dysfunctions: two 
(5.1%) had subclinical hypothyroidism, and eight 
(20.5%) were taking levothyroxine for clinical 
hypothyroidism. No patient was hyperthyroid. 
Seventeen (43.6%) patients were on a strict 
GFD, while 13 (33.3%) followed it often and five 
(12.8%) eventually followed the prescribed diet. 
Four (10.2%) patients never eliminated gluten 
from their diet.
Tables 1 and 2 summarize the demographic data 
of celiac patients with and without thyroid-related 
abnormalities. The associated comorbidities are 
shown in Table 3.
Six patients (15.4%) had positive anti-TPO 
antibodies: one with hypothyroidism, one with 
subclinical hypothyroidism, and four with normal 
thyroid function. The prevalence of thyroid-related
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Female [n(%)] 10 (100) 26 (89.7) 0.29
Patients on a GFD [n(%)] 3 (30) 14 (48.3) 0.31
Family history of CD [n(%)] 1 (10) 3 (10.3) 0.97
Family history of TD [n(%)] 5 (50) 12 (41.4) 0.63
Smoking [n(%)] 1 (10) 2 (6.9) 0.75
Pregnancies [n(%)] 2 (20) 5 (19.2) 0.67
Age (years) 53.3±14.5 49.9±12.8 0.48
Duration of CD (years) 5.0 (2.75-11.50) 5.0 (2.00-9.00) 0.68
Age of onset of CD (years) 45.9±17.9 44.5±12.1 0.78
BMI 23.58 ± 2.96 24.81 ± 3.82 0.36
Duration of GFD (years) 4.0 (2.0-11.50) 5.00 (2 - 9) 0.91
Duration of TD treatment (years) 4.0 (0.75-8.50) - -
TSH (mU/L) 4.4 (2.7-5.3) 2.2 (1.7-2.7) 0.009
Anti-TPO (IU/ml) 8.3 (5-46.1) 7.8 (5-13.5) 0.53
FT4 (ng/dL) 1.14±0.28 1.16±0.24 0.89
Table 1: Characteristics of celiac disease (CD) patients with and without normal thyroid function.
Thyroid dysfunction (TD): hypothyroidism (all taking levothyroxine) and subclinical hypothyroidism; GFD: gluten-free diet; BMI: body mass index; 
TSH: thyroid-stimulating hormone; TPO: thyroperoxidase; FT4: free thyroxine.  
Data are shown as number (n) and percentage (%), mean± standard deviation, and median (P25/P75). 
abnormalities was 35.9% (14 subjects) in the 
studied group. Mean serum FT4 levels were 
1.15 ± 0.25 ng/dl; median TSH levels were 2.4 
(0.1-6.6) IU/ml, and median anti-TPO levels were 
8.1 (5.0-44.17) IU/ml.
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GFD: gluten-free diet; TD: thyroid dysfunction; BMI: body mass index; TSH: thyroid-stimulating hormone; TPO: thyroperoxidase; FT4: free thyroxine.
Data are shown as number (n) and percentage (%), mean±standard deviation, or median (P25/P75).
Table 2: Characteristics of celiac disease (CD) patients with and without thyroid-related abnormalities 
(hypothyroidism, subclinical hypothyroidism or euthyroid autoimmune thyroid disease).
                                     Group





Female [n(%)] 14 (100) 22 (88) 0.25
Patients on a GFD [n(%)] 5 (35.7) 12 (48) 0.34
Family history of CD [n(%)] 1 (7.1) 3 (1.2) 0.54
Family history of TD [n(%)] 7 (50) 10 (40) 0.39
Smoking [n(%)] 1 (7.1) 2 (8) 0.71
Pregnancies [n(%)] 2 (0-8) 2.5 (0-5) 0.51
Age (years) 52.7±15.1 49.7±11.7 0.49
Duration of CD (years) 5.0 (2.0–9.0) 6.0 (2.0–9.0) 0.73
Age of onset of CD (years) 46.4±18.3 44.0±10.4 0.66
BMI (kg/m2) 23.9 ± 2.6 24.8±4.1 0.47
Duration of GFD (years) 4.0 (1.8–9.0) 5.00 (2.0–9.0) 0.63
Duration of TD treatment (years) 3.0 (0.0–8.0) - -
TSH (mIU/ml) 4.0 (2.1-5.1) 2.2 (1.6-2.7) 0.009
Anti-TPO (IU/ml) 24.2 (6.12-108.0) 7.13 (5-9.7)      0.013
FT4(ng/mL) 1.22 ± 0.33 1.12 ± 0.21 0.27
Additional diseases Number of patients %
Anxiety symptoms 22 56.4
Iron deficiency anemia 20 51.3
Osteopenia or osteoporosis 19 48.7
Depression symptoms 15 38.5
Lactose intolerance 10 25.6
Hepatic dysfunction* 6 15.4
Anemia due to folic acid deficiency 5 12.8
Hepatitis C 5 12.8
Cancer 4 10.3
Alopecia 4 10.3
Dermatitis herpetiformis 3 7.7
Type 1 diabetes mellitus 2 5.1
IgA deficiency 1 2.6
*Chronic liver disease of unknown etiology was diagnosed in one patient. An increased level of transaminases of unknown origin was later detected in five patients. 
Table 3: Frequency of comorbid problems in patients with celiac disease (n=39).
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tertiary care center. 
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